Influenza pandemics, whether mild, moderate or severe, affect a large proportion of the population and require a multisectoral response over several months or even years. For this reason, countries develop plans describing their strategies for responding to a pandemic supported by operational plans at national and subnational levels.
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
Page listing outbreak reports for the 2009 influenza A (H1N1) pandemic. The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.
Page listing surveillance reports for the 2009 influenza A (H1N1) pandemic. The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.
Influenza pandemics, whether mild, moderate or severe, affect a large proportion of the population and require a multisectoral response over several months or even years. For this reason, countries develop plans describing their strategies for responding to a pandemic supported by operational plans at national and subnational levels.
The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.
Location:Geneva, Switzerland
Organized by:International Alliance for Biological Standardisation and the World Health Organization
In November 2014, the Pharmacovigilance Centre of Netherlands (Lareb) provided an updated overview of Dutch cases of narcolepsy reported to have a link to Pandemrix.
This is the first published study where an attempt has been made to understand the possible biological mechanisms behind development of narcolepsy following vaccination with Pandemrix™.
This observational cohort study utilizing electronic health care records covering 5.8 million Swedes confirmed an increased risk of narcolepsy after vaccination with Pandemrix in children and adolescents (<